SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Nov-24 4:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 18-Nov-24 | Option Exercise | 10,000 | $1.59 | $15,900.00 | 9% 109.97K to 119.97K | |
20-Nov-24 4:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 18-Nov-24 | Planned Option Sale | 10,000 | $21.04 | $210,400.00 | (8%) 119.97K to 109.97K | |
20-Nov-24 4:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 18-Nov-24 | Sale (Planned) | 7,000 | $21.04 | $147,280.00 | (6%) 109.97K to 102.97K | |
25-Sep-24 4:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Sep-24 | Option Exercise | 10,000 | $1.59 | $15,900.00 | 8% 124.47K to 134.47K | |
25-Sep-24 4:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Sep-24 | Planned Option Sale | 10,000 | $24.99 | $249,900.00 | (7%) 134.47K to 124.47K | |
25-Sep-24 4:39 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Sep-24 | Sale (Planned) | 7,500 | $24.99 | $187,425.00 | (6%) 124.47K to 116.97K | |
04-Sep-24 8:53 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Payment of Exercise | 577 | $26.74 | $15,429.00 | (< 1%) 125.05K to 124.47K | |
04-Sep-24 8:53 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Option Exercise | 1,964 | -- | -- | 2% 123.09K to 125.05K | |
04-Sep-24 8:53 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Payment of Exercise | 1,322 | $26.74 | $35,350.30 | (1%) 124.41K to 123.09K | |
04-Sep-24 8:53 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Option Exercise | 4,499 | -- | -- | 4% 119.91K to 124.41K | |
29-Aug-24 4:36 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 27-Aug-24 | Option Exercise | 10,000 | $1.59 | $15,900.00 | 8% 127.41K to 137.41K | |
29-Aug-24 4:36 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 27-Aug-24 | Planned Option Sale | 10,000 | $26.91 | $269,100.00 | (7%) 137.41K to 127.41K | |
29-Aug-24 4:36 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 27-Aug-24 | Sale (Planned) | 7,500 | $26.91 | $201,825.00 | (6%) 127.41K to 119.91K | |
08-Apr-24 5:17 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 08-Apr-24 | Payment of Exercise | 801 | $17.90 | $14,337.90 | (< 1%) 126.83K to 126.02K | |
08-Apr-24 5:17 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 08-Apr-24 | Option Exercise | 2,726 | -- | -- | 2% 124.1K to 126.83K | |
03-Apr-24 5:23 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Apr-24 | Payment of Exercise | 521 | $19.70 | $10,263.70 | (< 1%) 124.62K to 124.1K | |
03-Apr-24 5:23 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Apr-24 | Option Exercise | 1,773 | -- | -- | 1% 122.85K to 124.62K | |
05-Mar-24 4:34 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Mar-24 | Option Exercise | 656 | $1.59 | $1,043.04 | < 1% 123.38K to 124.04K | |
05-Mar-24 4:34 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Mar-24 | Planned Option Sale | 656 | $22.03 | $14,451.70 | (< 1%) 124.04K to 123.38K | |
05-Mar-24 4:34 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Mar-24 | Sale (Planned) | 533 | $22.03 | $11,742.00 | (< 1%) 123.38K to 122.85K | |
06-Sep-23 7:04 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-23 | Payment of Exercise | 577 | $17.76 | $10,247.50 | (< 1%) 123.96K to 123.38K | |
06-Sep-23 7:04 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-23 | Option Exercise | 1,964 | -- | -- | 2% 121.99K to 123.96K | |
06-Sep-23 7:04 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-23 | Payment of Exercise | 801 | $17.76 | $14,225.80 | (< 1%) 122.79K to 121.99K | |
06-Sep-23 7:04 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-23 | Option Exercise | 2,727 | -- | -- | 2% 120.07K to 122.79K | |
11-Apr-23 5:03 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 10-Apr-23 | Payment of Exercise | 801 | $10.71 | $8,578.71 | (< 1%) 120.87K to 120.07K | |
11-Apr-23 5:03 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 10-Apr-23 | Option Exercise | 2,727 | -- | -- | 2% 118.14K to 120.87K | |
20-Mar-23 5:15 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 20-Mar-23 | Payment of Exercise | 876 | $11.12 | $9,741.12 | (< 1%) 119.02K to 118.14K | |
20-Mar-23 5:15 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 20-Mar-23 | Option Exercise | 2,982 | -- | -- | 3% 116.03K to 119.02K | |
20-Mar-23 5:15 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 16-Mar-23 | Payment of Exercise | 577 | $11.46 | $6,612.42 | (< 1%) 116.61K to 116.03K | |
20-Mar-23 5:15 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 16-Mar-23 | Option Exercise | 1,964 | -- | -- | 2% 114.65K to 116.61K | |
06-Sep-22 4:09 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-22 | Payment of Exercise | 577 | $11.44 | $6,600.88 | (< 1%) 115.22K to 114.65K | |
06-Sep-22 4:09 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-22 | Option Exercise | 1,964 | -- | -- | 2% 113.26K to 115.22K | |
06-Sep-22 4:09 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 15-Jul-22 | Grant | 1,048 | $9.56 | $10,018.90 | < 1% 112.21K to 113.26K | |
23-Mar-22 4:30 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 21-Mar-22 | Payment of Exercise | 1,461 | $10.98 | $16,041.80 | (1%) 113.67K to 112.21K | |
23-Mar-22 4:30 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 21-Mar-22 | Option Exercise | 4,611 | -- | -- | 4% 109.06K to 113.67K | |
18-Mar-22 4:36 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 16-Mar-22 | Payment of Exercise | 681 | $10.13 | $6,898.53 | (< 1%) 109.74K to 109.06K | |
18-Mar-22 4:36 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 16-Mar-22 | Option Exercise | 1,964 | -- | -- | 2% 107.78K to 109.74K | |
18-Mar-22 4:36 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 15-Jan-22 | Grant | 970 | $9.63 | $9,341.10 | < 1% 106.81K to 107.78K | |
18-Mar-22 4:36 PM View: | Kiniksa Pharmaceuticals Int... (KNSA) | 15-Jul-21 | Grant | 868 | $11.49 | $9,973.32 | < 1% 105.94K to 106.81K |